Related Experiment Videos
[Value of surgery in metastatic cancer of the kidney]
Abstract:
The authors analyse a series of 186 patients with renal cell carcinoma in which 33 patients of Stage IV, with metastases, underwent Nephrectomy and 3 had also operative removal of metastases appearing in early post nephrectomy follow up. The survival periods have been disappointing (none at 5 years). With a review of literature they discuss about the extent of nephrectomy, whether done with purely palliative aim, or along with attempted curative excision simultaneously of the associated metastases. Even if the spontaneous regressions are exceptional and the improvement of survival duration less frequent, metastases are not always a reason not to remove Renal Cell Carcinoma.
Insights
Nephrectomy (surgical removal of the kidney) for advanced renal cell carcinoma with metastases offers limited survival benefits. Despite disappointing outcomes, surgical intervention may still be considered in select cases.
Area of Science:
- Oncology
- Urology
- Surgical Oncology
Context:
- Analysis of 186 patients with renal cell carcinoma (RCC).
- Focus on 33 Stage IV patients with metastases undergoing nephrectomy.
- Inclusion of 3 patients with simultaneous metastases removal post-nephrectomy.
Purpose:
- To evaluate the survival outcomes of nephrectomy in Stage IV renal cell carcinoma patients with metastases.
- To discuss the extent of nephrectomy (palliative vs. curative) in conjunction with metastases management.
- To review literature regarding surgical intervention for metastatic RCC.
Summary:
- Nephrectomy was performed on 33 Stage IV RCC patients with metastases; 3 also had metastases removed post-surgery.
- Survival rates were poor, with no patients surviving 5 years.
- The study discusses the role of nephrectomy, even with metastases present, considering palliative and curative approaches.
Impact:
- Highlights the limited survival advantage of nephrectomy for metastatic RCC.
- Suggests that the presence of metastases should not automatically preclude surgical consideration for RCC.
- Informs clinical decision-making regarding surgical management of advanced renal cell carcinoma.